We sit down with you and build your perfect lead list. Book a call with founders.

Synsory Bio Analysis

What is Synsory Bio?

Synsory Bio develops advanced protein therapeutics that target diseased tissues, enhancing the efficacy of potent drugs for cancer and autoimmune disorders.

Founded
2023
Company Stage
Seed
Investors
- Y Combinator
YC Batch
W24

Product Features & Capabilities

  • next-generation protein therapeutics, synthetic sensing functions, conditional activation upon sensing disease markers, targeted activation at diseased tissue, potential applications in cancer and autoimmune disorders

Who are the founders of Synsory Bio

ET
NT

Find more companies like Synsory Bio

in Y Combinator Batch W24 Companies